Galectin Therapeutics (GALT) Preferred Dividend Payments (2010 - 2026)

Galectin Therapeutics' Preferred Dividend Payments history runs 17 years deep, the most recent figure standing at $21000.0 for Q1 2026.

• In Q1 2026, Preferred Dividend Payments rose 180.77% year-over-year to $21000.0; the TTM figure through Mar 2026 stood at $185000.0 (up 55.46% YoY), while the FY2025 annual figure was $138000.0, down 9.8% from the prior year.
• Preferred Dividend Payments was $21000.0 for Q1 2026 at Galectin Therapeutics, down from $62000.0 in the prior quarter.
• In the past five years, Preferred Dividend Payments ranged from a high of $65000.0 in Q4 2022 to a low of -$26000.0 in Q1 2025.
• Historically, Preferred Dividend Payments has averaged $33062.5 across 5 years, with a median of $50500.0 in 2025.
• The sharpest annual moves came in 2022 and 2024: Preferred Dividend Payments tumbled 900.0% in 2022, then soared 400.0% in 2024.
• A 5-year view of Preferred Dividend Payments shows it stood at $65000.0 in 2022, then dropped by 3.08% to $63000.0 in 2023, then changed by 0.0% to $63000.0 in 2024, then dropped by 1.59% to $62000.0 in 2025, then slumped by 66.13% to $21000.0 in 2026.
• The last three Preferred Dividend Payments figures came in at $21000.0 (Q1 2026), $62000.0 (Q4 2025), and $39000.0 (Q3 2025), per Business Quant data.